Global PET Radiopharmaceuticals Market Growth 2023-2028

Report ID: 1503274 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global PET Radiopharmaceuticals Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for PET Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for PET Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028
    2.2 PET Radiopharmaceuticals Segment by Type
        2.2.1 F-18
        2.2.2 Ru-82
        2.2.3 Others
    2.3 PET Radiopharmaceuticals Sales by Type
        2.3.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
        2.3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
        2.3.3 Global PET Radiopharmaceuticals Sale Price by Type (2017-2022)
    2.4 PET Radiopharmaceuticals Segment by Application
        2.4.1 Oncology
        2.4.2 Cardiology
        2.4.3 Neurology
        2.4.4 Others
    2.5 PET Radiopharmaceuticals Sales by Application
        2.5.1 Global PET Radiopharmaceuticals Sale Market Share by Application (2017-2022)
        2.5.2 Global PET Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)
        2.5.3 Global PET Radiopharmaceuticals Sale Price by Application (2017-2022)
3 Global PET Radiopharmaceuticals by Company
    3.1 Global PET Radiopharmaceuticals Breakdown Data by Company
        3.1.1 Global PET Radiopharmaceuticals Annual Sales by Company (2020-2022)
        3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2022)
    3.2 Global PET Radiopharmaceuticals Annual Revenue by Company (2020-2022)
        3.2.1 Global PET Radiopharmaceuticals Revenue by Company (2020-2022)
        3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
    3.3 Global PET Radiopharmaceuticals Sale Price by Company
    3.4 Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers PET Radiopharmaceuticals Product Location Distribution
        3.4.2 Players PET Radiopharmaceuticals Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for PET Radiopharmaceuticals by Geographic Region
    4.1 World Historic PET Radiopharmaceuticals Market Size by Geographic Region (2017-2022)
        4.1.1 Global PET Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global PET Radiopharmaceuticals Annual Revenue by Geographic Region
    4.2 World Historic PET Radiopharmaceuticals Market Size by Country/Region (2017-2022)
        4.2.1 Global PET Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)
        4.2.2 Global PET Radiopharmaceuticals Annual Revenue by Country/Region
    4.3 Americas PET Radiopharmaceuticals Sales Growth
    4.4 APAC PET Radiopharmaceuticals Sales Growth
    4.5 Europe PET Radiopharmaceuticals Sales Growth
    4.6 Middle East & Africa PET Radiopharmaceuticals Sales Growth
5 Americas
    5.1 Americas PET Radiopharmaceuticals Sales by Country
        5.1.1 Americas PET Radiopharmaceuticals Sales by Country (2017-2022)
        5.1.2 Americas PET Radiopharmaceuticals Revenue by Country (2017-2022)
    5.2 Americas PET Radiopharmaceuticals Sales by Type
    5.3 Americas PET Radiopharmaceuticals Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC PET Radiopharmaceuticals Sales by Region
        6.1.1 APAC PET Radiopharmaceuticals Sales by Region (2017-2022)
        6.1.2 APAC PET Radiopharmaceuticals Revenue by Region (2017-2022)
    6.2 APAC PET Radiopharmaceuticals Sales by Type
    6.3 APAC PET Radiopharmaceuticals Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe PET Radiopharmaceuticals by Country
        7.1.1 Europe PET Radiopharmaceuticals Sales by Country (2017-2022)
        7.1.2 Europe PET Radiopharmaceuticals Revenue by Country (2017-2022)
    7.2 Europe PET Radiopharmaceuticals Sales by Type
    7.3 Europe PET Radiopharmaceuticals Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa PET Radiopharmaceuticals by Country
        8.1.1 Middle East & Africa PET Radiopharmaceuticals Sales by Country (2017-2022)
        8.1.2 Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2017-2022)
    8.2 Middle East & Africa PET Radiopharmaceuticals Sales by Type
    8.3 Middle East & Africa PET Radiopharmaceuticals Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
    10.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
    10.4 Industry Chain Structure of PET Radiopharmaceuticals
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 PET Radiopharmaceuticals Distributors
    11.3 PET Radiopharmaceuticals Customer
12 World Forecast Review for PET Radiopharmaceuticals by Geographic Region
    12.1 Global PET Radiopharmaceuticals Market Size Forecast by Region
        12.1.1 Global PET Radiopharmaceuticals Forecast by Region (2023-2028)
        12.1.2 Global PET Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global PET Radiopharmaceuticals Forecast by Type
    12.7 Global PET Radiopharmaceuticals Forecast by Application
13 Key Players Analysis
    13.1 Cardinal Health Inc. (U.S.)
        13.1.1 Cardinal Health Inc. (U.S.) Company Information
        13.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offered
        13.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Cardinal Health Inc. (U.S.) Main Business Overview
        13.1.5 Cardinal Health Inc. (U.S.) Latest Developments
    13.2 Mallinckrodt plc (Ireland)
        13.2.1 Mallinckrodt plc (Ireland) Company Information
        13.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offered
        13.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Mallinckrodt plc (Ireland) Main Business Overview
        13.2.5 Mallinckrodt plc (Ireland) Latest Developments
    13.3 GE Healthcare (U.K.)
        13.3.1 GE Healthcare (U.K.) Company Information
        13.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offered
        13.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GE Healthcare (U.K.) Main Business Overview
        13.3.5 GE Healthcare (U.K.) Latest Developments
    13.4 Lantheus Medical Imaging, Inc. (U.S.)
        13.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information
        13.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offered
        13.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Lantheus Medical Imaging, Inc. (U.S.) Main Business Overview
        13.4.5 Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
    13.5 Bayer AG (Germany)
        13.5.1 Bayer AG (Germany) Company Information
        13.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Offered
        13.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Bayer AG (Germany) Main Business Overview
        13.5.5 Bayer AG (Germany) Latest Developments
    13.6 Bracco Imaging S.p.A (Italy)
        13.6.1 Bracco Imaging S.p.A (Italy) Company Information
        13.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offered
        13.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Bracco Imaging S.p.A (Italy) Main Business Overview
        13.6.5 Bracco Imaging S.p.A (Italy) Latest Developments
    13.7 Eczacibasi-Monrol Nuclear Products (Turkey)
        13.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information
        13.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offered
        13.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Main Business Overview
        13.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
    13.8 Nordion, Inc. (Canada)
        13.8.1 Nordion, Inc. (Canada) Company Information
        13.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offered
        13.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Nordion, Inc. (Canada) Main Business Overview
        13.8.5 Nordion, Inc. (Canada) Latest Developments
    13.9 Advanced Accelerator Applications S.A. (France)
        13.9.1 Advanced Accelerator Applications S.A. (France) Company Information
        13.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offered
        13.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Advanced Accelerator Applications S.A. (France) Main Business Overview
        13.9.5 Advanced Accelerator Applications S.A. (France) Latest Developments
    13.10 IBA Molecular Imaging (Belgium)
        13.10.1 IBA Molecular Imaging (Belgium) Company Information
        13.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offered
        13.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 IBA Molecular Imaging (Belgium) Main Business Overview
        13.10.5 IBA Molecular Imaging (Belgium) Latest Developments
14 Research Findings and Conclusion
List of Tables
    Table 1. PET Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. PET Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of F-18
    Table 4. Major Players of Ru-82
    Table 5. Major Players of Others
    Table 6. Global PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 7. Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 8. Global PET Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)
    Table 9. Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
    Table 10. Global PET Radiopharmaceuticals Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 11. Global PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
    Table 12. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 13. Global PET Radiopharmaceuticals Revenue by Application (2017-2022)
    Table 14. Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
    Table 15. Global PET Radiopharmaceuticals Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 16. Global PET Radiopharmaceuticals Sales by Company (2020-2022) & (K Pcs)
    Table 17. Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2022)
    Table 18. Global PET Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
    Table 20. Global PET Radiopharmaceuticals Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 21. Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution and Sales Area
    Table 22. Players PET Radiopharmaceuticals Products Offered
    Table 23. PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global PET Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 27. Global PET Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)
    Table 28. Global PET Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global PET Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Pcs)
    Table 31. Global PET Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)
    Table 32. Global PET Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 35. Americas PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 36. Americas PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 38. Americas PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 39. Americas PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 40. Americas PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
    Table 41. Americas PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 42. APAC PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)
    Table 43. APAC PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Table 44. APAC PET Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
    Table 46. APAC PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 47. APAC PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 48. APAC PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
    Table 49. APAC PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 50. Europe PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 51. Europe PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 52. Europe PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 54. Europe PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 55. Europe PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 56. Europe PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
    Table 57. Europe PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 59. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 63. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2017-2022) & (K Pcs)
    Table 65. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of PET Radiopharmaceuticals
    Table 67. Key Market Challenges & Risks of PET Radiopharmaceuticals
    Table 68. Key Industry Trends of PET Radiopharmaceuticals
    Table 69. PET Radiopharmaceuticals Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. PET Radiopharmaceuticals Distributors List
    Table 72. PET Radiopharmaceuticals Customer List
    Table 73. Global PET Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 74. Global PET Radiopharmaceuticals Sales Market Forecast by Region
    Table 75. Global PET Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 78. Americas PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC PET Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 80. APAC PET Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 82. Europe PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa PET Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 84. Middle East & Africa PET Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global PET Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 86. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global PET Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global PET Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 90. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global PET Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Cardinal Health Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 94. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offered
    Table 95. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 96. Cardinal Health Inc. (U.S.) Main Business
    Table 97. Cardinal Health Inc. (U.S.) Latest Developments
    Table 98. Mallinckrodt plc (Ireland) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 99. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offered
    Table 100. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 101. Mallinckrodt plc (Ireland) Main Business
    Table 102. Mallinckrodt plc (Ireland) Latest Developments
    Table 103. GE Healthcare (U.K.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 104. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offered
    Table 105. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 106. GE Healthcare (U.K.) Main Business
    Table 107. GE Healthcare (U.K.) Latest Developments
    Table 108. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 109. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offered
    Table 110. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 111. Lantheus Medical Imaging, Inc. (U.S.) Main Business
    Table 112. Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
    Table 113. Bayer AG (Germany) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 114. Bayer AG (Germany) PET Radiopharmaceuticals Product Offered
    Table 115. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 116. Bayer AG (Germany) Main Business
    Table 117. Bayer AG (Germany) Latest Developments
    Table 118. Bracco Imaging S.p.A (Italy) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 119. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offered
    Table 120. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 121. Bracco Imaging S.p.A (Italy) Main Business
    Table 122. Bracco Imaging S.p.A (Italy) Latest Developments
    Table 123. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 124. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offered
    Table 125. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 126. Eczacibasi-Monrol Nuclear Products (Turkey) Main Business
    Table 127. Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
    Table 128. Nordion, Inc. (Canada) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 129. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offered
    Table 130. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 131. Nordion, Inc. (Canada) Main Business
    Table 132. Nordion, Inc. (Canada) Latest Developments
    Table 133. Advanced Accelerator Applications S.A. (France) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 134. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offered
    Table 135. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 136. Advanced Accelerator Applications S.A. (France) Main Business
    Table 137. Advanced Accelerator Applications S.A. (France) Latest Developments
    Table 138. IBA Molecular Imaging (Belgium) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 139. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offered
    Table 140. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 141. IBA Molecular Imaging (Belgium) Main Business
    Table 142. IBA Molecular Imaging (Belgium) Latest Developments
List of Figures
    Figure 1. Picture of PET Radiopharmaceuticals
    Figure 2. PET Radiopharmaceuticals Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global PET Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global PET Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. PET Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of F-18
    Figure 10. Product Picture of Ru-82
    Figure 11. Product Picture of Others
    Figure 12. Global PET Radiopharmaceuticals Sales Market Share by Type in 2021
    Figure 13. Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
    Figure 14. PET Radiopharmaceuticals Consumed in Oncology
    Figure 15. Global PET Radiopharmaceuticals Market: Oncology (2017-2022) & (K Pcs)
    Figure 16. PET Radiopharmaceuticals Consumed in Cardiology
    Figure 17. Global PET Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Pcs)
    Figure 18. PET Radiopharmaceuticals Consumed in Neurology
    Figure 19. Global PET Radiopharmaceuticals Market: Neurology (2017-2022) & (K Pcs)
    Figure 20. PET Radiopharmaceuticals Consumed in Others
    Figure 21. Global PET Radiopharmaceuticals Market: Others (2017-2022) & (K Pcs)
    Figure 22. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Figure 23. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2021
    Figure 24. PET Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Company in 2021
    Figure 26. Global PET Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021
    Figure 28. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region in 2021
    Figure 30. Americas PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)
    Figure 31. Americas PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
    Figure 32. APAC PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)
    Figure 33. APAC PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
    Figure 34. Europe PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)
    Figure 35. Europe PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa PET Radiopharmaceuticals Sales 2017-2022 (K Pcs)
    Figure 37. Middle East & Africa PET Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
    Figure 38. Americas PET Radiopharmaceuticals Sales Market Share by Country in 2021
    Figure 39. Americas PET Radiopharmaceuticals Revenue Market Share by Country in 2021
    Figure 40. United States PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC PET Radiopharmaceuticals Sales Market Share by Region in 2021
    Figure 45. APAC PET Radiopharmaceuticals Revenue Market Share by Regions in 2021
    Figure 46. China PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2021
    Figure 53. Europe PET Radiopharmaceuticals Revenue Market Share by Country in 2021
    Figure 54. Germany PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country in 2021
    Figure 61. Egypt PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country PET Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2021
    Figure 67. Manufacturing Process Analysis of PET Radiopharmaceuticals
    Figure 68. Industry Chain Structure of PET Radiopharmaceuticals
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global PET Radiopharmaceuticals Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global PET Radiopharmaceuticals Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global PET Radiopharmaceuticals Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports